Spatial and genomic profiling of residual breast cancer after neoadjuvant chemotherapy unveil divergent fates for each breast cancer subtype.

Cell Rep Med · 2025 · PMC12208320 · PMID 40482645

Europe PMC DOI

hedged sentence

0.0724

closest p · 1.4× alpha

0.0724

boldest claim

The sentences

did not reach statistical significancep = 0.0724so close (0.05 < p ≤ 0.1)

In addition, basal-like cancer cell enrichment correlated significantly with poorer RFS (hazard ratio: 1.12, 95% CI: 1.12–1.26, p < 0.0001, Figure S5 E) but did not reach statistical significance regarding OS (hazard ratio: 0.88, 95% CI: 0.77–1.01, p = 0.0724, Figure S5 D).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.